Literature DB >> 10578306

Prolongation of concordant xenograft survival by a newly developed drug, FTY720.

I Fujiwara1, H Nakajima, T Matsuda, N Mizuta, H Yamagishi, T Oka.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10578306     DOI： 10.1016/s0041-1345(99)00582-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  1 in total

1.  The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection.

Authors:  Alessandra Gonçalves Commodaro; Juliana Figueredo Pedregosa; Jean Pierre Peron; Wesley Brandão; Luiz Vicente Rizzo; Valquiria Bueno
Journal:  Clinics (Sao Paulo)       Date:  2012-07       Impact factor: 2.365
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.